User profiles for Emanuele Nicastri
 | Emanuele NicastriINMI Spallanzani Verified email at inmi.it Cited by 19125 |
[PDF][PDF] Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Human monoclonal antibodies are safe, preventive, and therapeutic tools that can be rapidly
developed to help restore the massive health and economic disruption caused by the …
developed to help restore the massive health and economic disruption caused by the …
[HTML][HTML] Compassionate use of remdesivir for patients with severe Covid-19
…, ML Green, FX Lescure, E Nicastri… - … England Journal of …, 2020 - Mass Medical Soc
Background Remdesivir, a nucleotide analogue prodrug that inhibits viral RNA polymerases,
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …
has shown in vitro activity against SARS-CoV-2. Methods We provided remdesivir on a …
[HTML][HTML] Epidemiological, clinical and virological characteristics of four cases of monkeypox support transmission through sexual contact, Italy, May 2022
Since May 2022, an outbreak of monkeypox has been ongoing in non-endemic countries. We
report four cases in Italy in young adult men reporting condomless sexual intercourse. The …
report four cases in Italy in young adult men reporting condomless sexual intercourse. The …
[HTML][HTML] Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 …
…, FS Serino, M Tsilika, P Bakakos, E Nicastri… - Nature medicine, 2021 - nature.com
Early increase of soluble urokinase plasminogen activator receptor (suPAR) serum levels is
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
indicative of increased risk of progression of coronavirus disease 2019 (COVID-19) to …
[HTML][HTML] Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
F Cantini, L Niccoli, D Matarrese, E Nicastri… - The Journal of …, 2020 - ncbi.nlm.nih.gov
As discussed in the Journal recently1 the SARS-CoV-2, a new β-Coronavirus, uses the
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is mediated …
Angiotensin Converting Enzyme-2 Receptor to enter airway cells. Viral endocytosis is mediated …
[HTML][HTML] First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
…, M Valette, B Lina, F Riccardo, E Nicastri… - …, 2020 - eurosurveillance.org
In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020.
We detail the first European cases. As at 21 February, nine European countries reported 47 …
We detail the first European cases. As at 21 February, nine European countries reported 47 …
Monkeypox virus isolation from a semen sample collected in the early phase of infection in a patient with prolonged seminal viral shedding
…, K Mizzoni, AR Garbuglia, E Nicastri… - The Lancet Infectious …, 2022 - thelancet.com
The unexpected increase in human monkeypox cases in non-endemic countries that began
in May, 2022, is raising concerns of a novel global infectious threat. Since the first human …
in May, 2022, is raising concerns of a novel global infectious threat. Since the first human …
[HTML][HTML] Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis
…, F Castelli, FS Serino, E Nicastri… - The Lancet …, 2021 - thelancet.com
Background Anakinra might improve the prognosis of patients with moderate to severe
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
COVID-19 (ie, patients requiring oxygen supplementation but not yet receiving organ support). …
SARS-CoV-2 isolation from ocular secretions of a patient with COVID-19 in Italy with prolonged viral RNA detection
…, E Lalle, L Bordi, P Marsella, E Nicastri… - Annals of internal …, 2020 - acpjournals.org
Background: Coronavirus disease 2019 (COVID-19), the disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in China in …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that originated in China in …
[HTML][HTML] Development of a clinical decision support system for severity risk prediction and triage of COVID-19 patients at hospital admission: an international …
…, A D'Abramo, V Schininà, E Nicastri… - European …, 2020 - Eur Respiratory Soc
Background The outbreak of coronavirus disease 2019 (COVID-19) has globally strained
medical resources and caused significant mortality. Objective To develop and validate a …
medical resources and caused significant mortality. Objective To develop and validate a …
